127 related articles for article (PubMed ID: 24029252)
21. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients.
Hagen M; Hjelmesaeth J; Jenssen T; Morkrid L; Hartmann A
Nephrol Dial Transplant; 2003 Oct; 18(10):2154-9. PubMed ID: 13679495
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance and insulin secretion in renal transplant recipients with hepatitis C.
Uchida J; Iwai T; Machida Y; Kuwabara N; Kabei K; Kumada N; Nakatani T
Transplant Proc; 2013 May; 45(4):1540-3. PubMed ID: 23726615
[TBL] [Abstract][Full Text] [Related]
23. New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials.
First MR; Dhadda S; Croy R; Holman J; Fitzsimmons WE
Transplantation; 2013 Jul; 96(1):58-64. PubMed ID: 23619735
[TBL] [Abstract][Full Text] [Related]
24. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
Madhu SV; Muduli SK; Avasthi R
Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
[TBL] [Abstract][Full Text] [Related]
25. beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus.
Nam JH; Mun JI; Kim SI; Kang SW; Choi KH; Park K; Ahn CW; Cha BS; Song YD; Lim SK; Kim KR; Lee HC; Huh KB
Transplantation; 2001 May; 71(10):1417-23. PubMed ID: 11391229
[TBL] [Abstract][Full Text] [Related]
26. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
27. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation.
Shabir S; Jham S; Harper L; Ball S; Borrows R; Sharif A
Transpl Int; 2013 Mar; 26(3):315-21. PubMed ID: 23279163
[TBL] [Abstract][Full Text] [Related]
28. Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipients.
Kälble F; Seckinger J; Schaier M; Morath C; Schwenger V; Zeier M; Sommerer C
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28581202
[TBL] [Abstract][Full Text] [Related]
29. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL
Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968
[TBL] [Abstract][Full Text] [Related]
30. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
31. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
Henninger J; Hammarstedt A; Rawshani A; Eliasson B
BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
[TBL] [Abstract][Full Text] [Related]
32. Prevention and management of new-onset diabetes mellitus in kidney transplantation.
Juan Khong M; Ping Chong Ch
Neth J Med; 2014 Apr; 72(3):127-34. PubMed ID: 24846925
[TBL] [Abstract][Full Text] [Related]
33. Is basiliximab induction, a novel risk factor for new onset diabetes after transplantation for living donor renal allograft recipients?
Prasad N; Gurjer D; Bhadauria D; Gupta A; Srivastava A; Kaul A; Jaiswal A; Yadav B; Yadav S; Sharma RK
Nephrology (Carlton); 2014 Apr; 19(4):244-50. PubMed ID: 24447227
[TBL] [Abstract][Full Text] [Related]
34. Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
Reddy YN; Abraham G; Sundaram V; Reddy PP; Mathew M; Nagarajan P; Mehra N; Ramachandran A; Ali AA; Reddy YN
Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1113-20. PubMed ID: 26586047
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
[TBL] [Abstract][Full Text] [Related]
36. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of glucose abnormalities and diagnostic value of fasting glucose and fasting insulin in urban Hispanics.
Hoffmann IS; Alfieri AB; Cubeddu LX
Am J Ther; 2013; 20(4):369-75. PubMed ID: 23528370
[TBL] [Abstract][Full Text] [Related]
38. Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation.
Strøm Halden TA; Åsberg A; Vik K; Hartmann A; Jenssen T
Nephrol Dial Transplant; 2014 Apr; 29(4):926-33. PubMed ID: 24452849
[TBL] [Abstract][Full Text] [Related]
39. Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.
Tillmann FP; Schmitz M; Rump LC; Quack I
Int Urol Nephrol; 2018 Apr; 50(4):771-777. PubMed ID: 29197933
[TBL] [Abstract][Full Text] [Related]
40. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients.
Midtvedt K; Hartmann A; Hjelmesaeth J; Lund K; Bjerkely BL
Nephrol Dial Transplant; 1998 Feb; 13(2):427-31. PubMed ID: 9509457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
